Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-31

FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved OLOPATADINE HYDROCHLORIDE ophthalmic solution under an Original Application for allergic conjunctivitis. The applicant is Padagis Israel Pharmaceut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

ORIG AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)